ASPR is the Secretary's principal advisor on matters related to bioterrorism and other public health emergencies. They are responsible for coordinating interagency activities between HHS, other Federal departments, agencies, offices and State and local officials responsible for emergency preparedness and the protection of the civilian population from acts of bioterrorism and other public health emergencies. The ASPR also works closely with global partners to address common threats around the world, enhancing national capacities to detect and respond to such threats, and to learn from each other’s experiences as another step toward national health security for the United States and other countries. The United States
National Response Framework (NRF) is part of the National Strategy for Homeland Security that presents the guiding principles enabling all levels of domestic response partners to prepare for and provide a unified national response to disasters and emergencies. Building on the existing National Incident Management System (NIMS) as well as Incident Command System (ICS) standardization, the NRF's coordinating structures are always in effect for implementation at any level and at any time for local, state, and national emergency or disaster response.
Public Health Emergency Medical Countermeasures Enterprise The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) is an interagency coordinating body led by the ASPR. It coordinates the development, acquisition, stockpiling, and recommendations for using
medical countermeasures to deal with public health emergencies. Along with
Biomedical Advanced Research and Development Authority (BARDA), it includes internal HHS partners at the
Food and Drug Administration (FDA), the
National Institutes of Health (NIH), and the
Centers for Disease Control and Prevention (CDC), along with external inter-agency partners at the
Department of Defense (DoD), the
United States Department of Homeland Security (DHS), the
United States Department of Agriculture (USDA), and the
United States Department of Veterans Affairs (VA).
Manhattan Project for Biodefense In July 2019, the
Blue Ribbon Study Panel on Biodefense announced a new idea to improve U.S. national security against
bioterrorism: a "Manhattan Project for Biodefense." The idea is a "proposed national, public-private research and development undertaking that would defend the United States against biological threats" and is publicly supported by retired U.S. Senator
Joseph Lieberman, the co-chair of the panel, and
Robert Kadlec, former U.S. Assistant Secretary for Preparedness and Response. Kadlec remarked, “We highly endorse such an endeavor in the sense of it’s time to say, ‘Go big or go home’ on this issue." == History ==